Is JNP stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
On Friday 21st of November 2014, Juniper Pharmaceuticals had a stock price of $5.95. If you invested back then, your return now would be a profit of $5.55 per share or 93.28%
Yes, the average daily trading liquidity for Juniper Pharmaceuticals is $1.25 million. You should therefore be able to get in and out of your positions relatively fast.
Juniper Pharmaceuticals has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.56, the company's ability to pay off the debt is good. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Juniper Pharmaceuticals to be low [0.3 out of 1]